Migraine and use of combined hormonal contraceptives: a clinical review
作者： E Anne MacGregor
DOI: 10.1783/147118907781004750
关键词: Epidemiology 、 Combined oral contraceptives 、 Family planning 、 Developed country 、 Gynecology 、 Hormone 、 Population 、 Medicine 、 Desogestrel 、 Pediatrics 、 Migraine
摘要: Headache is a common condition affecting the majority of women at some time in their lives. Epidemiological studies migraine also confirm that up to one-third will experience particularly during fertile years. Studies suggesting young associated with an increased risk ischaemic stroke have led particular concerns regarding additional effect other factors such as use combined oral contraceptives (COCs). This paper reviews COCs on headache and considers data COC users migraine. evidence be used support practical guidance management wishing COCs. Whilst presented based there no suggest effects hormonal (CHCs) are any different. Until further available different routes delivery following recommendations apply all CHCs. (excerpt)
nhsgrampian.org参考文章(99)
Marmot Mg, Chang Cl, Poulter Nr, Farley Tm, Meirik O, Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international multicenter case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception. ,vol. 57, ,(1998)
Edwin R Bickerstaff, Neurological complications of oral contraceptives Clarendon Press. ,(1975)
Leon Speroff, Marc A. Fritz, Clinical gynecologic endocrinology and infertility ,(1983)
Patricia J. Sulak, Thomas J. Kuehl, Mirian Ortiz, Bobby L. Shull, Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms American Journal of Obstetrics and Gynecology. ,vol. 186, pp. 1142- 1149 ,(2002) , 10.1067/MOB.2002.122988
S. Mazal, Migraine attacks and increased platelet aggregability induced by oral contraceptives. Australian and New Zealand Journal of Medicine. ,vol. 8, pp. 646- 648 ,(1978) , 10.1111/J.1445-5994.1978.TB04856.X
J.N Blau, Migraine: theories of pathogenesis. The Lancet. ,vol. 339, pp. 1202- 1207 ,(1992) , 10.1016/0140-6736(92)91140-4
K. Fotherby, Clinical experience and pharmacological effects of an oral contraceptive containing 20μg oestrogen Contraception. ,vol. 46, pp. 477- 488 ,(1992) , 10.1016/0010-7824(92)90151-I
M. E. Bigal, J. N. Liberman, R. B. Lipton, Age-dependent prevalence and clinical features of migraine Neurology. ,vol. 67, pp. 246- 251 ,(2006) , 10.1212/01.WNL.0000225186.76323.69
Johan Brohult, Ola Forsberg, Richard Hellström, A case of multiple arterial thromboses after oral contraceptives and ergotamine. Acta Medica Scandinavica. ,vol. 181, pp. 453- 456 ,(2009) , 10.1111/J.0954-6820.1967.TB07263.X